Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MANCHESTER, NH--(Marketwired - Sep 16, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to treat diabetes...
-
MANCHESTER, NH--(Marketwired - Sep 15, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), developer of complex carbohydrate therapeutics to treat diabetes, announced that David Platt, Ph.D., Chief...
-
MANCHESTER, NH--(Marketwired - Sep 5, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), developer of complex carbohydrate therapeutics to treat diabetes, announced that David Platt, Ph.D.,...
-
MANCHESTER, NH--(Marketwired - Aug 20, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, has completed enrollment of its Phase IIb...
-
MANCHESTER, NH--(Marketwired - Aug 18, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, has appointed noted diabetes...
-
MANCHESTER, NH--(Marketwired - Aug 8, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a leading developer of compounds that address diabetes using complex...
-
MANCHESTER, NH--(Marketwired - Aug 5, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of complex carbohydrate therapeutics to treat diabetes,...
-
MANCHESTER, NH--(Marketwired - Jul 30, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes, is sponsoring a symposium to be held at...
-
MANCHESTER, NH--(Marketwired - Jul 29, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases, has appointed...
-
MANCHESTER, NH--(Marketwired - Jul 9, 2014) - Boston Therapeutics, Inc. (OTCQB: BTHE), a developer of complex carbohydrate therapeutics to treat diabetes and inflammatory diseases, has appointed...